Macrophage IL-1β turns meningeal fibroblasts into inflammatory amplifiers in pneumococcal infection

Paul Beckenbauer1, Linda Ercegovac1, Greta Christensen1

  • 1Department of Neurology, Ludwig-Maximilians-University (LMU) University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Abstract

Insights

Meningeal fibroblasts amplify inflammation in pneumococcal meningitis. Macrophage-derived IL-1β drives this response, highlighting a potential therapeutic target for central nervous system infections.

Area of Science:

  • Neuroimmunology
  • Infectious Diseases

Background:

  • Pneumococcal meningitis triggers severe inflammation and neurological damage.
  • The role of meningeal fibroblasts in this response is poorly understood.

Purpose of the Study:

  • To investigate the contribution of meningeal fibroblasts to the immune response against Streptococcus pneumoniae.

Main Methods:

  • Primary meningeal fibroblasts were challenged with S. pneumoniae.
  • Cytokine responses were measured in monoculture and co-culture with macrophages.

Main Results:

  • Fibroblasts produced specific cytokines independently of Toll-like receptor signaling.
  • Macrophages significantly enhanced fibroblast cytokine production via IL-1β.
  • IL-1β was identified as the key activator of meningeal fibroblasts.

Conclusions:

  • An IL-1β-driven axis between macrophages and fibroblasts amplifies inflammation in pneumococcal meningitis.
  • This axis represents a potential therapeutic target for CNS infections.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...